TrialThe New England journal of medicine2019
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.
Seock-Ah Im et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
524 papers cite itlatest 60 shown
this paperpooled ittrialcites it